Found 6 matching trials
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
PHASE2This is a Phase 2a, randomized, open-label, multicenter study to assess the...
Location
Multiple Locations
RDEA3170 and Febuxostat Combination Study in Gout Subjects
PHASE2This is a Phase 2a, randomized, open-label, multicenter study to assess the...
Location
Multiple Locations
RDEA3170 Bioavailability Study
PHASE1This is a Phase 1, randomized, open-label, 4-way crossover pharmacokinetic ...
Location
Multiple Locations
Single and Multiple Dose Study in Japanese Subjects
PHASE1This study will explore the safety, tolerability, and serum uric acid lower...
Location
Multiple Locations
RDEA3170 Tablet and Capsule Bioavailability Study
PHASE1The purpose of this study is to determine the relative bioavailability of R...
Location
Multiple Locations
A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients
PHASE1The purpose of this study is to explore the pharmacodynamics (PD), pharmaco...